MedPath
NMPA Approval

lingzhi capsule

国药准字Z44020201

August 7, 2019

Drug Information

灵芝胶囊

胶囊剂

每粒装0.27g

中药

August 7, 2019

Company Information

Manufacturing Company

广州市海珠区南石路1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

灵芝胶囊 - NMPA 批准文号 | MedPath